Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 High-grade prostate cancer in the Prostate Cancer Prevention Trial: fact or artifact?

× No keyword cloud information.

5 in total

1. 5-Alpha Reductase Inhibitors and the Risk of Prostate Cancer Mortality in Men Treated for Benign Prostatic Hyperplasia.

Authors: Lauren P Wallner; Julia R DiBello; Bonnie H Li; Stephen K Van Den Eeden; Sheila Weinmann; Debra P Ritzwoller; Jill E Abell; Ralph D'Agostino; Ronald K Loo; David S Aaronson; Kathryn Richert-Boe; Ralph I Horwitz; Steven J Jacobsen
Journal: Mayo Clin Proc Date: 2016-10-27 Impact factor: 7.616

2. The Use of 5-Alpha Reductase Inhibitors to Manage Benign Prostatic Hyperplasia and the Risk of All-cause Mortality.

Authors: Lauren P Wallner; Julia R DiBello; Bonnie H Li; Stephen K Van Den Eeden; Sheila Weinmann; Debra P Ritzwoller; Jill E Abell; Ralph D'Agostino; Ronald K Loo; David S Aaronson; Ralph I Horwitz; Steven J Jacobsen
Journal: Urology Date: 2018-06-12 Impact factor: 2.649

3. The relevance of serum levels of long chain omega-3 polyunsaturated fatty acids and prostate cancer risk: A meta-analysis.

Authors: Michael E Chua; Maria Christina D Sio; Mishell C Sorongon; Marcelino L Morales
Journal: Can Urol Assoc J Date: 2013 May-Jun Impact factor: 1.862

4. Prostate cancers detected during 5α-reductase inhibitor use are smaller, de-differentiated, but confined when compared to controls.

Authors: Fred Lee; Robert A Badalament; Chen Hu; Ingrid Bousho; Alex Tsodikov
Journal: J Cancer Date: 2012-03-07 Impact factor: 4.207

5. Association of 5-alpha-reductase inhibitor and prostate cancer incidence and mortality: a meta-analysis.

Authors: Xu Hu; Yao-Hui Wang; Zhi-Qiang Yang; Yan-Xiang Shao; Wei-Xiao Yang; Xiang Li
Journal: Transl Androl Urol Date: 2020-12

5 in total